Fred Cohen

Insider profile

Currently holds positions in Rapid Micro Biosystems, Inc., CareDx, Inc., Veracyte, Inc., Progyny Inc and Intellia Therapeutics Inc

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 20% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 33% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Rapid Micro Biosystems, Inc. None -
Independent Director CareDx, Inc. Jan. 1, 2003 -
Independent Director Veracyte, Inc. Jan. 1, 2013 -
Independent Director Progyny Inc March 1, 2015 -
Independent Director Intellia Therapeutics Inc Jan. 23, 2019 -
Independent Director Genomic Health Inc April 1, 2002 - Nov. 8, 2019
Independent Director Tandem Diabetes Care, Inc. Jan. 1, 2013 - June 1, 2019
Director BioCryst Pharmaceuticals, Inc. July 23, 2013 - Jan. 4, 2019
Independent Director Five Prime Therapeutics Inc May 1, 2002 - May 10, 2018
Independent Director Sorrento Tech Inc Sept. 1, 2009 - Oct. 2, 2017
Director IQVIA Holdings Inc May 8, 2007 - Nov. 5, 2015
Fred Cohen's trades of Intellia Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Progyny Inc (PGNY)
Transaction date
Proposed sale
Price
17.46
Quantity 89,083
Value US$3,981,050
Transaction date
Sale
Price
163.94
Quantity 9,797 -34.6%
Value US$1,689,367
Transaction date
Sale
Price
26.79
Quantity 35,847 -89.6%
Value US$960,320
Transaction date
Sale
Price
79.57
Quantity 693 -1.0%
Value US$55,142
Transaction date
Sale
Price
78.80
Quantity 9,307 -12.0%
Value US$733,417
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-07 2026-01-05
B Purchase
13,763 -47.2%
299.29
US$4,416,024 		13,763 -47.2% 299.29 US$4,416,024
2025-06-03 2025-06-03
US Progyny Inc (PGNY)
PrS Proposed sale
89,083
17.46
US$3,981,050 		89,083 17.46 US$3,981,050
2020-05-19 2020-05-18
S Sale
9,797 -34.6%
163.94
US$1,689,367 		9,797 -34.6% 163.94 US$1,689,367
2020-05-19 2020-05-18
S Sale
35,847 -89.6%
26.79
US$960,320 		35,847 -89.6% 26.79 US$960,320
2019-02-26 2019-02-22
S Sale
693 -1.0%
79.57
US$55,142 		693 -1.0% 79.57 US$55,142
2019-02-26 2019-02-22
S Sale
9,307 -12.0%
78.80
US$733,417 		9,307 -12.0% 78.80 US$733,417